Latest Trials
Latest News
FAQ
Pharmaceutical Companies
Pharma Details
Otologic Pharmaceutics, Inc.
🇺🇸
United States
Country
🇺🇸
United States
Ownership
Holding
Established
2009-01-01
Employees
1
Market Cap
-
Website
http://otologicpharma.com
Clinical Trials
Related News
Study to Determine the Safety, Tolerability, and Pharmacokinetic Profile of HPN-07 and HPN-07 Plus NAC
Phase 1
Completed
Conditions
Hearing Loss
Sensorineural Hearing Loss
Noise-Induced Hearing Loss
Interventions
Drug: HPN-07
Drug: Placebo
Drug: NAC
Subscribe
First Posted Date
2014-10-08
Last Posted Date
2015-05-01
Lead Sponsor
Otologic Pharmaceutics, Inc.
Target Recruit Count
32
Registration Number
NCT02259595
Locations
🇺🇸
Wake Research Associates, Raleigh, North Carolina, United States
Subscribe
Prev
1
Next
© Copyright 2024. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy